Rapport Therapeutics, Inc. (RAPP) Institutional Ownership

Institutions by Trading Activity

Ownership Statistics

0Shares Outstanding

22,332,089Shares held by institutions

$622,172,000Value of institutional holdings

108.82%Institutional ownership %

-5.18%Shares Changed QoQ

80No. of institutional investors

Shares Owned by Institutions

Shares Purchased/Sold by Institutions

Ownership Summary

Rapport Therapeutics, Inc. (NASDAQ:RAPP) is held by 140 institutional investors per 13F filings through December 2025.

Collectively, these holders controlled 132.8% of Rapport Therapeutics's outstanding shares in December 2025, up from 130.3% in September 2025.
They increased total shares held in Rapport Therapeutics by 6.77% from the prior quarter, while the number of investors in RAPP increased 100.0% year over year.
During the quarter, 90 of these 140 funds increased positions in RAPP, 30 reduced exposure, and 20 held steady.
In total, institutional investors held 50.36Mn shares in Rapport Therapeutics as of December 2025, up by 3.19Mn shares quarter on quarter, and up 13.91Mn shares year over year.
TRV GP V, LLC is the top holder of Rapport Therapeutics as of December 31, 2025, with 7.14Mn shares representing 18.81% of outstanding stock.
The largest buyers of Rapport Therapeutics for the quarter ending December 2025 were BlackRock, Inc. (863.78K), Goldman Sachs Group Inc (579.9K), State Street Corp (343.2K), PERCEPTIVE ADVISORS LLC (270.0K), Prudential Financial Inc (254.97K).
The largest sellers of Rapport Therapeutics for the quarter ending December 2025 were Siren, L.L.C. (345.0K), UBS Group AG (331.71K), ADAGE CAPITAL PARTNERS GP, L.L.C. (300.0K), SILVERARC CAPITAL MANAGEMENT, LLC (194.29K), Cormorant Asset Management, LP (165.0K).
According to Business Quant data, leading holders of RAPP for December 2025 are TRV GP V, LLC (7.14Mn), FMR LLC (7.11Mn), ARCH Venture Management, LLC (3.73Mn), Capital International Investors (3.4Mn), Cormorant Asset Management, LP (3.03Mn), Goldman Sachs Group Inc (3.0Mn), BlackRock, Inc. (2.43Mn), Sofinnova Investments, Inc. (1.9Mn), VANGUARD GROUP INC (1.82Mn), Johnson & Johnson (1.78Mn).

140 Institutional Holders

22,332,089 Total Shares Held

Rows:

Download Data

Owner Name	Date	Change (QoQ)	Change (%)	Value (USD)
BlackRock, Inc.	31 Dec, 2025	863,781	55.09%	$0.00
FMR LLC	31 Dec, 2025	194,870	2.82%	$0.00
TRV GP V, LLC	31 Dec, 2025	0	0.00%	$0.00
Johnson & Johnson	31 Dec, 2025	0	0.00%	$0.00
ARCH Venture Management, LLC	31 Dec, 2025	0	0.00%	$0.00
Sofinnova Investments, Inc.	31 Dec, 2025	-43,171	-2.22%	$0.00
Barclays Plc	31 Dec, 2025	12,904	32.61%	$0.00
Capital International Investors	31 Dec, 2025	0	0.00%	$0.00
Vestal Point Capital, LP	31 Dec, 2025	160,000	16.84%	$0.00
Cormorant Asset Management, LP	31 Dec, 2025	-165,000	-5.17%	$0.00
Polar Capital Holdings Plc	31 Dec, 2025	65,776	7.01%	$0.00
Goldman Sachs Group Inc	31 Dec, 2025	579,903	23.94%	$0.00
TRV GP VI, LLC	31 Dec, 2025	0	0.00%	$0.00
VANGUARD GROUP INC	31 Dec, 2025	191,219	11.76%	$0.00
T. Rowe Price Investment Management, Inc.	31 Dec, 2025	146,290	20.68%	$0.00
Siren, L.L.C.	31 Dec, 2025	-345,000	-32.75%	$0.00
BAKER BROS. ADVISORS LP	31 Dec, 2025	0	0.00%	$0.00
Burkehill Global Management, LP	31 Dec, 2025	0	0.00%	$0.00
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	31 Dec, 2025	60,113	6.74%	$0.00
UBS Group AG	31 Dec, 2025	-331,713	-59.44%	$0.00

1 - 20 of 140

Research Tools